Previous Close | 3.8500 |
Open | 3.9200 |
Bid | 4.0000 x 100 |
Ask | 4.0700 x 100 |
Day's Range | 3.9200 - 4.1950 |
52 Week Range | 3.6200 - 8.0500 |
Volume | |
Avg. Volume | 1,372,500 |
Market Cap | 1.185B |
Beta (5Y Monthly) | 0.36 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, British Columbia, May 01, 2024--AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
VANCOUVER, British Columbia, April 08, 2024--AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
VANCOUVER, British Columbia, April 03, 2024--AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.